Recursion Pharmaceuticals Inc - Class A (RXRX) Earnings Report - Forecasts and Surprise Ratio

Quarterly Earnings History

RXRX ratio: 20%

100%

RXRX beat 3 of 15 last estimates

Date of next report: Feb 25, 2025

Estimate for Q4 24: $-0.35

Implied change from Q3 24: +2.94%

Implied change from Q4 23: -12.50%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 6, 2024	$-0.34 / $-0.33	$-0.01 / -3.03%
Q2 24	Aug 8, 2024	$-0.4 / $-0.35	$-0.05 / -14.29%
Q1 24	May 9, 2024	$-0.39 / $-0.43	$0.04 / 9.3%
Q4 23	Feb 27, 2024	$-0.4 / $-0.46	$0.06 / 13.04%
Q3 23	Nov 9, 2023	$-0.43 / $-0.38	$-0.05 / -13.16%
Q2 23	Aug 8, 2023	$-0.38 / $-0.38	$0 / -
Q1 23	May 8, 2023	$-0.34 / $-0.34	$0 / -
Q4 22	Feb 27, 2023	$-0.31 / $-0.15	$-0.16 / -106.67%

Data Vendor: Xignite Logo